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Abstract Despite being initially identified in mice, little is
known about the sites of production of members of the BPI
fold (BPIF) containing (PLUNC) family of putative innate
defence proteins in this species. These proteins have largely
been considered to be specificaly expressed in the respira-
tory tract, and we have recently shown that they exhibit
differential expression in the epithelium of the proximal
airways. In this study, we have used species-specific anti-
bodies to systematically localize two members of this pro-
tein family; BPIFA1 (PLUNC/SPLUNC1) and BPIFB1
(LPLUNC1) in adult mice. In general, these proteins exhibit
distinct and only partially overlapping localization. BPIFA1
is highly expressed in the respiratory epithelium and Bow-
man’s glands of the nasal passages, whereas BPIFB1 is
present in small subset of goblet cells in the nasal passage
and pharynx. BPIFB1 is also present in the serous glands in
the proximal tongue where is co-localised with the salivary
gland specific family member, BPIFA2E (parotid secretory
protein) and also in glands of the soft palate. Both proteins
exhibit limited expression outside of these regions. These
results are consistent with the localization of the proteins
seen in man. Knowledge of the complex expression patterns
of BPIF proteins in these regions will allow the use of
tractable mouse models of disease to dissect their function.
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Background
Palate lung nasal epithelium clone (PLUNC) was first de-
scribed in the nasal epithelium of the mouse embryo and the
trachea/bronchi of adult mice (Weston et al. 1999). We cloned
the human and mouse PLUNC genes (Bingle and Bingle.
2000; LeClair et al. 2001), and subsequently made the key
observation that PLUNC belongs to a group of proteins that
make up the largest branch of a lipid transfer protein family.
This group includes phospholipid transfer protein (PLTP),
cholesterol ester transfer protein (CETP), bactericidal perme-
ability increasing protein (BPI) and LPS-binding protein
(LBP) (Bingle and Craven 2002; Bingle and Craven 2004;
Bingle et al. 2004). Structural similarity across the PLUNC/
BPI family suggested that these proteins would function by
binding lipid molecules (Beamer et al. 1997; Bingle and
Craven 2004), and this led to the hypothesis that PLUNCs
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may share host defence functions with BPI and LBP (Bingle
and Craven. 2002).
PLUNC proteins are encoded by genes in a single locus
on human chromosome 20q11, and conserved loci are found
in all mammals. PLUNC proteins encoded by these genes
were originally grouped into short (SPLUNC1 etc.) and long
(LPLUNC1 etc.) proteins on the basis of structural homolo-
gy to the domains of BPI, with SPLUNCs having structural
similarity to the N-terminal domain of BPI, and LPLUNCs
having structural similarity to both domains (Bingle and
Craven. 2002). Due to the increasing complexity of this gene
family and conflicting gene nomenclature, a new, compre-
hensive nomenclature has recently been developed. Within
this framework, all family members have been renamed
using the root symbol BPIF# for “BPI fold containing”.
Family members that contain a single domain have the
designation BPIFA (so that SPLUNC1/PLUNC becomes
BPIFA1), and those containing two domains have the desig-
nation BPIFB (so that LPLUNC1 becomes BPIFB1) (Bingle
et al. 2011b).
BPIF genes are amongst the most rapidly evolving mam-
malian genes and there is significant interspecies diversity in
the wider family, particularly within the BPIFA branch
(Bingle et al. 2004; Bingle et al. 2011a). The interspecies
diversity and rapid evolution support a role for these pro-
teins in host defence, although compelling functional data is
only just starting to emerge (Wright et al. 2010; Gally et al.
2011; Lukinskiene et al. 2011). BPIFA1 has also been
shown to have a surfactant-like function (Gakhar et al.
2010), and also to be involved in the activation of the
sodium channel, ENaC (Garcia-Caballero et al. 2009). The
sites of expression of BPIF proteins are not well-
characterised, and indeed many of the genes have never
been studied. However, existing data indicate that these
genes are predominantly expressed in locations where in-
nate defence is a major requirement, namely in the nasal,
tracheal, and bronchial passages, as well as in major salivary
glands and minor mucosal glands of the oral cavity
(reviewed in Bingle and Bingle. 2011). Expression of these
genes outside of these regions has also been shown, includ-
ing Bpifa1 in the mouse thymus (LeClair et al. 2001) and
Bpifb1 in the gastrointestinal tract (LeClair et al. 2001; Hou
et al 2004). The prototypic two BPI-domain containing
protein, BPIFB1 (LPLUNC1) and the founding family
member BPIFA1 (SPLUNC1/PLUNC) are highly expressed
in the upper respiratory tract (reviewed in Bingle and Bingle
2011). These two family members are present in all mam-
mals (Bingle, Seal and Craven. 2011), and both are also
readily detectable in human nasal secretions, bronchoalveo-
lar lavage (BAL), and sputum (Casado et al. 2005; Wu et al.
2005; Nicholas et al. 2006).
Despite initially being cloned in mice, these genes are
actually less well-described in this species. Bpifa1 is
expressed in the respiratory epithelium of the nasal passages,
as well as in the large airways (Weston, et al 1999; LeClair et
al. 2001; Genter et al. 2003; LeClair et al. 2004). Similar
nasal expression domains have been shown in the rat (Sung
et al. 2002). Our observations on the expression of Bpifb1 in
the epithelium and minor glands of the dorsal tongue and in
the large airways, along with the report of expression in the
early embryo, remain the only studies of expression of this
gene in mice (Hou et al. 2004; LeClair et al. 2004). In
contrast, there is extensive information concerning the
localisation and expression of mouse and rat BPIFA2E
(previously known as parotid secretory protein/psp) in
the major salivary glands (reviewed in Ball et al. 2003).
Indeed, this protein is the best studied member of this
family.
In the present study, we have used mouse specific anti-
bodies to BPIFA1 and BPIFB1 to carry out an extensive
analysis of protein localisation in the nasal and oral cavities
of adult mice. Knowledge of the patterns of BPIF proteins in
these regions will be useful to inform studies of mouse
models of disease to dissect their function.
Materials and methods
Generation of mouse specific BPIFA1 and BPIFB1 antibodies
Affinity-purified, peptide–specific, polyclonal antibodies
against murine BPIFA1 and BPIFB1were generated in rabbits
using established methods (Eurogentec, Seraing, Belgium).
For each protein, two anti-peptide antibodies were produced.
For BPIFA1 antibody “A” the peptide sequence was: 189-
199: (AVKDNQGRIHL), and for BPIFA1 antibody “B” the
peptide sequence was 31-46: (GPPLPLNQGPPLPLNQ).
This second region is absolutely unique for the mouse protein,
as it is encoded by a mouse-specific insertion into exon 2. For
BPIFB1 antibody “A”, the peptide sequence was: 140-150:
(RVERSKSGPAH) located in the first BPI domain of
BPIFB1, and for BPIFB1 antibody “B” the peptide sequence
was 268-279: (LMETTPDRAPFS) in the second BPI domain.
These peptides were chosen so as to have minimal sequence
conservation between man and mouse, and no similarity with
other members of the BPIF family. Bioinfomatic analysis also
showed that the epitopes had no significant sequence identity
with any other mouse proteins. Each individual peptide was
used to affinity purify the final antibodies. We used the same
methods to generate an antibody against mouse BPIFA2E
(parotid secretory protein) using the peptide sequence
CSSNTDKISISLLGRR corresponding to amino acids 161-
176 (Khovidhunkit et al. 2005). (Eurogentec, Seraing, Bel-
gium). This antibody was used as a comparator in studies of
salivary glands as this protein is well-studied in these regions
(Ball et al 2003).
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Sample collection
Mice strains C57BL6 and C57BL6/129sv were used in this
study. They were housed in the DePaul University and the
University of Sheffield animal care facilities, and were
allowed access to food and water ad libitum. All studies
were performed with full local ethics approval. We collected
an extensive range of tissues from mice aged from 6 to
16 weeks, with some tissues being collected following per-
fusion fixation and all samples being fixed in cold 4 %
paraformaldehyde. Where required, decalcification was per-
formed using formic acid. Fixed tissues were embedded in
paraffin according to standard protocols.
Immunohistochemistry
Immunostaining was performed on 4-μm paraffin sections
mounted onto glass slides (SuperFrost Plus, VWR interna-
tional, Belgium). Slides were dried in the oven for 90 minutes
to ensure the sections were firmly attached. All reactions
followed standard protocols. Sections were deparaffinized
and rehydrated. Endogenous peroxidase activity was blocked
by quenching the sections in 3 % H2O2 in methanol for
20 minutes. The sections were then rinsed in PBS, and where
necessary (for antibodies to BPIFB1) antigen retrieval was
performed using tri-sodium citrate buffer for 8 minutes in a
microwave oven followed by rinsing in PBS. Sections were
incubated in 100 % normal goat serum for 30 minutes at room
temperature in a humidified chamber. The serum was drained
and replaced with primary antibody diluted in 100 % normal
goat serum. Optimal antibody dilutions were determined em-
pirically, and the final dilutions used were 1:750 BPIFA1,
1:750: BPIFB1, 1:500 PBIFA2E (Psp) and 1:500 MUC5B
(H-300: sc-20119, Santa Cruz). Primary antibodies were left
on the sections overnight at 4 °C in a humidified chamber.
Rabbit IgG (DAKO) was used in place of the primary anti-
body as a negative control on representative slides, and a
duplicate section was always used as a no primary antibody
control. A Vectastain Elite ABC kit (Vector Laboratories)
containing a goat anti-rabbit biotin-labelled secondary anti-
body was used according to the manufacturer’s instructions.
Peroxidase enzymatic development was performed using a
Vector NovaRed substrate kit, resulting in red staining in
positive cells. Sections were counterstained with haematoxy-
lin, dehydrated to xylene, andmounted in DPX. On occasions,
Alcian blue staining of acidic mucus was performed using
standard histological protocols prior to staining with BPIFA1.
Results
Although Bpifa1 (plunc/splunc1) was initially cloned from
mice, limited published information exists on the sites of
expression in this species. To inform our choice of tissue
samples, we interrogated mouse tissue expression datasets
(Su et al. 2004) on the BioGPS portal, http://biogps.org (Wu
et al. 2009) for expression of bpifa1 and bpifb1. This anal-
ysis suggested that both genes have very limited expression
domains and are broadly found in similar regions of the
nasal cavities, including the nasal septum, the nasal septal
organ, the vomeronasal organ (VNO), and the olfactory
epithelium, as well as in the trachea and to a lesser extent
the lung (Sup Fig. 1). These data also indicated that bpifb1 is
expressed in the stomach.
BPIFA1 and BPIFB1 are differentially expressed
in the nasopharyngeal regions
Because of the low level of sequence similarity between
human and mouse BPIF proteins, we generated mouse-
specific antibodies against BPIFA1 and BPIFB1 for use in
our studies. Both BPIFA1 antibodies and one BPIFB1 anti-
body (Antibody “B”) worked well for immunohistochemistry
(IHC), and crucially they failed to show specific staining in
tissue samples from mice deficient in BPIFA1 and BPIFB1
(Sup Fig. 2). We have also recently used these antibodies for
the identification of the proteins in mouse bronchoalveolar
lavage (BAL) fluid, and to show the differential localisation of
the proteins in the respiratory tract (Bingle et al. 2012).
Given the original isolation of bpifa1 from the mouse
nasal septum, we surveyed the localisation of BPIFA1 in the
adult head using a series of coronal sections starting from
the snout. Within the anterior nasal cavity, most of the
surface is covered with squamous epithelium, and in this
region BPIFA1 is present in the patches of respiratory epi-
thelium (Fig. 1a) on the lateral surface. The transitional
epithelium overlaying the nasal septum was negative. In
more caudal/posterior sections there was always a very clear
demarcation between staining in the respiratory epithelium
(Fig. 1b–f) and complete lack of staining in the transitional
epithelium and olfactory epithelium of these regions. No
staining was seen in the lateral nasal gland (Fig. 1b), vom-
eronasal organ (VNO), or associated minor septal glands
(Fig. 1e). In more distal regions of olfactory epithelium
associated with the dorsal medial meatus and the dorsal
lateral meatus, staining of some Bowman’s glands and Bow-
man’s gland ducts was seen (Fig. 1g, h). In this region,
BPIFA1 was found to be associated with the cell surface
and in the mucous of the nasal passages. Closer examination
of the respiratory epithelium from the nasal passages sug-
gests that the BPIFA1 was present in non-ciliated cells.
When we examined the localisation of BPIFB1 in similar
sections, there were clear differences in intensity of staining
and cellular localisation. Specifically, BPIFB1 expression is
much more restricted. In anterior sections, BPIFB1 was
limited to a population of goblet cells on the lateral surface
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of the nasal septum (Fig. 2a), whereas BPIFA1 staining was
much stronger in the respiratory epithelium (Fig. 2b). Ex-
pression of BPIFB1 in goblet cells was confirmed at higher
magnification of sections of the proximal septum (Fig. 2c);
however, the nasal septal glands lacked expression. Goblet
cells around and within the vomeronasal gland ducts and
serous acinar cells within the gland were also positive for
staining. However, the mucous portions of the gland were
negative (Fig. 2d). In more posterior sections of the snout,
there was no staining of BPIFB1 in the olfactory epithelium
and Bowman’s glands (not shown), nor in the lateral nasal
glands and the septal organ (Fig. 2e). In marked contrast to
the situation seen with BPIFA1, only a very small number of
cells in the respiratory epithelium of the nasopharyngeal
meatus stained with BPIFB1 (Fig. 2f). In other sections,
we did not observe staining for either protein in lacrimal
Fig. 1 Distribution of BPILA1
in adult mouse nasal passages.
Immunohistochemistry for
BPIFA1 was performed as
described in Materials and
methods section. Sections show
staining in samples of
nasopharyngeal tissues
sectioned it a proximal to distal
manner. RE 0 respiratory
epithelium, S 0 septum, LNG 0
lateral nasal gland, OE 0
olfactory epithelium, VNO 0
vomeronasal organ, NPM 0
nasopharyngeal meatus, BG 0
Bowman’s gland, BGD 0
Bowman’s gland duct
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glands, Harderian glands, Zymbal glands, or sebaceous
glands (results not shown).
BPIFB1 is predominantly localised to the serous cells
of the minor glands of the proximal tongue and the soft palate
Analysis of sections of proximal tongue revealed that
BPIFA1 staining was always negative (Fig. 3a). In contrast,
the minor serous glands stained strongly with BPIFB1
(Fig. 3b, e), whereas the mucous glands were predominantly
negative (Fig. 3b, d). Higher power views of the mucous
glands did on occasion show a small number of BPIFB1-
positive cells within the mucous acini (Fig. 3d). A similar,
but less homogenous staining pattern was seen with BPI-
FA2E (Fig. 3c, f) but the protein was never detected in the
mucous glands. BPIFB1 was also observed in the serous
component of the seromucous glands overlying the soft
palate (Fig. 3h), whereas staining for BPIFA1 and BPIFA2E
staining was not observed (Fig. 3g, i). The surface epithelium
of the proximal tongue and the soft palate was negative for
all three proteins.
BPIFA1 and BPIFB1 are differentially expressed in larynx
Examination of the larynx showed that both proteins were
present in the submucosal glands and ducts associated with
this region (Fig. 4), but they appeared in different cells.
Strong BPIFA1 was seen in cells of the ducts and within
the luminal contents (Fig. 4a, b), with weaker staining in
some of the serous and mucous cells of the glands them-
selves (Fig. 4c). The squamous epithelium lining the larynx
was negative for staining; however, where this epithelium
transitioned into respiratory epithelium at the opening of the
trachea, strong staining was seen (Fig. 4a). In contrast,
BPIFB1 did not stain the ductal epithelium but rather the
luminal contents (Fig. 4d, e) as well as the serous cells of the
submucosal glands, (Fig. 4f). Again, the squamous epithe-
lium was negative for staining. The submucosal glands
Fig. 2 Distribution of BPILB1
in adult mouse nasal passages.
Immunohistochemistry for
BPIFB1 was performed as
described in materials and
methods section. Sections show
staining in samples of proximal
nasal septum (a), and more
distal regions of the
nasopharynx (c-f) Staining of
BPIFA1 in the proximal nasal
septum is shown for
comparison (b) with a. S 0
septum, NSG 0 nasal septal
gland, VNG 0 vomeronasal
gland, SO 0 septal organ, LNG
0 lateral nasal gland, NPM 0
nasopharyngeal meatus
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surrounding the larynx appear to represent the only site in
the mouse where these two proteins are co-expressed within
the same gland.
BPIFA1 and BPIFB1 exhibit limited expression in other tissues
Given our previous data on expression of human BPIF
proteins in the major salivary glands (Bingle et al. 2005;
Bingle et al. 2007; Bingle et al. 2010), we next studied
samples of the three major salivary glands: the sublingual
gland, the submandibular gland, and the parotid gland. In
contrast to the situation seen in man, neither BPIFA1
(Fig. 5a, b) or BPIFB1 (Fig. 5c, d), were detected in any
of these glands. Abundant BPIFA2E was detected in the
serous demilunes of the sublingual gland (Fig. 5e) and
throughout the serous acini of the parotid gland (Fig. 5f),
but not in the submandibular gland.
We systematically analysed additional adult mouse tis-
sues for expression of both proteins, to confirm that they
were both predominantly expressed in the oral, nasopharyn-
geal, and respiratory tissues. Specifically, we did not see
expression in the kidney (Sup Fig. 3a, b), heart, liver,
pancreas, spleen, testes, or ovaries (data not shown). We
focused on the GI tract, given the previous data showing
bpifb1 expression in the stomach and neonatal GI tract
(LeClair et al. 2004; Hou et al. 2004) and the recent reports
of expression of human proteins in this region (Sentani et al.
2008: Shin et al. 2011). A survey of sections from the
Fig. 3 Distribution of BPIF
proteins in the minor glands of
the proximal mouse tongue and
soft palate.
Immunohistochemistry for
BPIFA1 (a, g), BPIFB1 (b, d, e,
h) and BPIFA2E (c, f, i) was
performed in serial sections as
described in materials and
methods section. Sections show
staining of the proximal tongue
(a-f) and seromucus glands in
the roof of the soft palate (g-h)
Fig. 4 Distribution of BPIF
proteins in the adult mouse
larynx. Immunohistochemistry
for BPIFA1 (a-c) and BPIFB1
(d-f) was performed in serial
sections as described in
materials and methods section.
Sections show staining in
regions of the epithelium and
associated glands
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oesophagus to the rectum revealed that there was a popula-
tion of BPIFB1-positive cells in the fundus of the gastric
glands (Sup Fig. 3d). BPIFA1 was not seen in this location
(Sup Fig. 3c) and neither protein was seen in any other
regions of the GI tract, including the ileum and colon (Sup
Fig. 3e, f and g, h respectively).
Discussion
Despite the fact that both bpifa1 and bpifb1 were originally
cloned from mouse heads over 10 years ago (bpifa1 from
nasal tissue and bpifb1 from proximal tongue), information
on their expression domains is quite limited and is exclu-
sively based on RNA expression. One of the most interest-
ing observations on members of the wider BPIF-family is
that they share relatively limited sequence similarity both
within and between species (Bingle et al. 2004: Bingle,
Bingle and Craven. 2011). This key observation has allowed
us to generate a series of unique species-specific antibodies
to study BPIFA1 and BPIFB1 localisation in mice. Our
study of these two proteins in adult mice has allowed us to
gain a fuller understanding of the sites of production, and
has confirmed that both proteins are largely confined to
regions of the head and upper respiratory tract. We have
also recently reported that the two proteins are expressed in
distinct epithelial cell populations in the airway. BPIFA1 is
expressed in non-ciliated cells of the upper airway and the
bronchial passages, whereas BPIFB1 stains a limited popu-
lation of goblet cells in the upper airways. Neither protein is
expressed in the small airways or in peripheral lung tissue
(Bingle et al 2012). In this report, we described the system-
atic localisation of BPIFA1 or BPIFB1 in the mouse, a
model that will be of value in understanding the biological
function of these proteins.
Bpifa1 was originally identified in developing nasal pas-
sages and the upper respiratory tract of adult mice (Weston
et al. 1999). Our immunohistochemical analysis confirms
Fig. 5 BPIFA1 and BPIFB1
are not expressed in the major
salivary glands of the mouse.
Immunohistochemistry for
BPIFA1 (a, b), BPIFB1 (c, d)
and BPIFA2E (e, f) was
performed in serial sections of
sublingual gland (a, c, e) and
parotid and submandibular
glands (b, d, f) as described in
materials and methods section.
SGM – submandibular gland;
Par – parotid gland
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that these are the major sites of expression. The most intense
staining for BPIFA1 is in regions of the nasal passages, and
within these regions the protein is localised to epithelial
cells within the respiratory epithelium. This is also consis-
tent with previous studies of rat bpifa1 (Sung et al. 2002).
The protein is not found in the squamous, transitional, or
olfactory epithelium. The protein is associated with mucoid
secretions of the nasal turbinates as well as with the ciliated
surface overlying the olfactory epithelium. It seems likely
that BPIFA1 is secreted by Bowman’s glands, as both the
glands and their associated ducts stain strongly for BPIFA1.
The protein does not seem to be produced by any of the
other multiple minor glands associated with the nasal pas-
sages, nor does it appear to be produced by the vomeronasal
or the nasal septal organs. Consistent with this localisation,
the protein is readily detected in nasal washes by Western
blotting (results not shown), and the data suggest that the
protein is secreted into the mucosal lining fluids in these
locations where it likely plays a host defence role.
Mouse bpifb1 was originally cloned (NCBI accession
number U46068) from minor glands of the proximal tongue
and our in situ hybridization studies confirmed this, along
with expression in the epithelium of the upper airways
(LeClair et al. 2004). The present study further confirms
that the protein is found in the serous portions of minor
glands of the proximal tongue. Interestingly, here it appears
to be expressed in the same cells as the well-studied rodent
family member, BPIFA2E (formally known as parotid se-
cretory protein) (Ball et al. 2003). Such co-localisation is the
exception rather than the rule, as BPIFB1 is not produced in
the sublingual and parotid glands, which strongly express
BPIFA2E. Conversely, BPIFB1 is expressed in the serous
demilunes of the seromucus glands of the soft palate, where
BPIFA2E is not expressed. In the submucosal glands of the
larynx (and trachea), BPIFB1 and BPIFA1 are present in
different cellular compartments. BPIFB1 is found in the
serous cells, whereas BPIFA1 is present in mucous cells.
This distribution mirrors that seen in human airway submu-
cosal glands and other minor mucosal glands (Bingle et al.
2005; Bingle et al. 2010). It remains to be determined why
members of this family exhibit such a precise spatial ex-
pression pattern within these glands, given that secretory
products from the serous and mucous cells ultimately end up
being secreted into the same biological fluids. Interestingly,
there do appear to be interspecies differences in the distri-
bution of BPIF proteins in the major salivary glands.
BPIFA1 and BPIFB1 are expressed in human major salivary
glands (Bingle et al. 2005; Vargas et al 2009; Bingle et al.
2010), and are readily detected in saliva (Ramachandran et
al. 2006; Walz et al. 2006; Siqueira et al. 2008), but our data
shows that they are absent, or lowly expressed, in adult
mouse salivary glands. Furthermore, in mouse, BPIFA2E
(parotid secretory protein) is a major component of saliva
accounting for 20-30 % of salivary protein, whereas levels
of the closest human orthologue of the protein in man,
BPIFA2, are much less.
In addition to being present in the serous compartment of
tongue minor glands, BPIFB1 is also present in a subset of
what appear to be goblet cells within the nasopharynx This
is particularly evident in sections through the nasal cavity
and within the nasopharynx (Fig. 2). As we have previously
reported for the human protein, not all goblet cells in these
regions produce the protein (Sup Fig. 4), and goblet cells in
other locations, including the GI tract (Sup Fig 3) and the
conjunctiva (data not shown), do not stain for BPIFB1.
Outside of the head, neck, and upper respiratory tract, it
appears that both of these proteins have limited expression in
adult mouse tissues. Mouse bpifa1 expression was originally
reported in the adult mouse heart (Weston et al. 1999), whilst
other studies have suggested that the gene is expressed in
models of cardiomyopathy (Bekeredjian et al. 2010). We
have been unable to detect the protein in normal adult heart
tissues by immunohistochemistry, suggesting that the protein
is either absent from this tissue or is produced at levels below
the limit of detection by IHC. Human BPIFA1 expression has
also been reported in the stomach, colon, and kidney, leading
to the suggestion that it plays a role in the regulation of
processing of the sodium channel, ENaC in these location
(Garcia-Caballero et al. 2009). We were unable to detect the
protein in mouse kidney, nor in any portions of the mouse GI
tract from the stomach to the rectum. This may reflect a true
difference between species, or again may be due to the fact
that expression is very low in these tissues, and below the
detection limit of the IHC technique.
We previously reported that bpifb1 was expressed in the
prenatal GI tract (LeClair et al. 2004). Expression has also
been reported in the adult mouse stomach (Hou et al. 2004;
Kallio et al. 2010) as well as in the developing wallaby
stomach (Kwek et al. 2009). Our protein studies support
these observations, showing that BPIFB1 is present in a
population of cells within the gastric fundus. We were
unable to detect the protein in any other regions of the GI
tract, suggesting that it is not a significant product of the
gastrointestinal mucosa. As far as we are aware, the protein
has not previously been reported in the mouse GI tract, but
we have recently shown that the protein is present in a
population of Paneth cells in the human duodenum (Shin
et al. 2011), where it has been shown to decrease pro-
inflammatory responses to V. cholerae and E. coli LPS.
In summary, we have shown that the two most abundant-
ly expressed members of the mouse BPIF protein family,
BPIFA1 and BPIFB1, are localised to a number of epithelial
cell types and minor mucosal glands associated with the
nose, mouth, and respiratory tract. BPIFA1 is most strongly
expressed in the nasal respiratory epithelium, whereas
BPIFB1 appears to be most strongly expressed in the minor
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glands of the proximal tongue. There is limited expression
of BPIFB1 in a population of goblet cells in the nasophar-
ynx. As is the case in man, the two proteins are produced by
different epithelial cell types, and may play host defence
roles in the mucosal fluids in these locations. Understanding
where these proteins are produced in the mouse will be of
benefit to future functional studies on these and other mem-
bers of the BPIF family.
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